Crystalline form of gamma-aminobutyric acid analog

Details for Australian Patent Application No. 2004282192 (hide)

Owner Xenoport, Inc.

Inventors Raillard, Stephen P.; Frauenfelder, Christine; Estrada, Tono; Zacher, Uwe

Agent Davies Collison Cave

Pub. Number AU-B-2004282192

PCT Pub. Number WO2005/037784

Priority 60/511,287 14.10.03 US

Filing date 14 October 2004

Wipo publication date 28 April 2005

Acceptance publication date 20 January 2011

International Classifications

C07C 271/22 (2006.01) Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 9/20 (1970.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/22 (2006.01) Medicinal preparations characterised by special physical form - Sustained or differential release type

A61K 9/26 (1970.01) Medicinal preparations characterised by special physical form - Discrete particles in supporting matrix

Event Publications

27 April 2006 PCT application entered the National Phase

  PCT publication WO2005/037784 Priority application(s): WO2005/037784

20 January 2011 Application Accepted

  Published as AU-B-2004282192

19 May 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004282193-Substituted aryl cycloalkanol derivatives and methods of their use

2004282189-Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases